Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study
Open Access
- 2 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 13 (1), 1
- https://doi.org/10.1186/1476-511x-13-1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Meta-Analysis of Safety of the Coadministration of Statin With Fenofibrate in Patients With Combined HyperlipidemiaThe American Journal of Cardiology, 2012
- LDL Cholesterol: The Lower the BetterMedical Clinics of North America, 2012
- FenofibrateDrugs, 2011
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementEuropean Heart Journal, 2011
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of AtorvastatinMayo Clinic Proceedings, 2010
- Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed DyslipidemiaThe American Journal of Cardiology, 2008
- Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosisMedical Hypotheses, 2004
- The triglyceride–high-density lipoprotein axis: An important target of therapy?American Heart Journal, 2004
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993